Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease [version 1; peer review: 2 approved]
The discovery of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) system has revolutionized gene editing research. Through the repurposing of programmable RNA-guided CRISPR-associated (Cas) nucleases, CRISPR-based genome editing systems allow for the precise modification of spe...
Main Authors: | Catherine Baker, Matthew S. Hayden |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-04-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/9-281/v1 |
Similar Items
-
Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease [version 2; peer review: 2 approved]
by: Catherine Baker, et al.
Published: (2020-10-01) -
What’s new in HIV dermatology? [version 1; peer review: 2 approved]
by: Sarah J Coates, et al.
Published: (2019-06-01) -
SpEDIT: A fast and efficient CRISPR/Cas9 method for fission yeast [version 1; peer review: 2 approved]
by: Sito Torres-Garcia, et al.
Published: (2020-11-01) -
The genetics of intellectual disability: advancing technology and gene editing [version 1; peer review: 2 approved]
by: Muhammad Ilyas, et al.
Published: (2020-01-01) -
A CRISPR/Cas9 genome editing pipeline in the EndoC-βH1 cell line to study genes implicated in beta cell function [version 1; peer review: 2 approved, 1 approved with reservations]
by: Antje K. Grotz, et al.
Published: (2019-10-01)